When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KALA - Kala Still Has A Shot To Reach Its Goal For Approval After Latest Setback
Kala Pharmaceuticals Inc.
Kala Pharmaceuticals (KALA) announced that the FDA had given it a complete response letter ((CRL)) for its dry eye disease treatment KPI-121 0.25%. While this was disappointing news for both the company and its investors, there is still another shot on goal. That is, it may be possible for the biotech to resubmit its NDA to the FDA after the completion of a phase 3 study. With that mind, there is still an opportunity to obtain FDA approval for this product. Even then, the company's already approved product by the FDA, known as